In the early 1990s, a professor and student at St. John's University in New York developed a technology to bring tricky water-insoluble drugs to the generic market, eventually earning themselves tens of millions of dollars, while leaving the university where the research took place high and dry.Or at least that's what court documents filed in the New York Supreme Court in Queens on November 18 seem to allege. When reached last week by telephone at his New Jersey number, the professor - Sanford Bolton - had yet to be served with the suit. "I absolutely feel I have done nothing wrong," Bolton told The Scientist. "I was a professor there. I published many papers. I was chairman of the department. I was well-respected."Bolton, who is 79, retired from College of Pharmacy at St. John's University in 1994 and maintains his primary residence in a housing development in Tucson, where he...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!